Health and Medical News Acorda Therapeutics Inc said the Food and Drug Administration rejected its nasal form of the current standard therapy for epilepsy patients who experience repetitive seizures. The biotechnology company's shares fell as much as 11 percent afte...
by via @ Health and Medical News
by via @ Health and Medical News